Search results
Pages
-
- Population pharmacokinetics of treosulfan in paediatric patients undergoing hematopoietic stem cell transplantation
-
- Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39
-
- Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease
-
- Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact
-
- Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
-
- Transcriptome Signature Reversion as a Method to Reposition Drugs Against Cancer for Precision Oncology
-
- The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples
-
- A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
-
- Validation of a clinical pharmacogenetic model to predict methotrexate nonresponse in rheumatoid arthritis patients
-
- Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device
-
- Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants
-
- Food-effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteers
-
- Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab
-
- Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers
-
- Genetic polymorphisms of 3-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy